Home › Kanser sa Tiyan › Nebraska › Omaha

Pag-aaral pangklinika para sa Kanser sa Tiyan sa Omaha, NE

9 pag-aaral para sa Kanser sa Tiyan ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Omaha (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo

Alegent Health Immanuel Medical Center, Omaha
Alegent Health Bergan Mercy Medical Center, Omaha
Alegent Health Lakeside Hospital, Omaha

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07283939

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Alegent Health Immanuel Medical Center, Omaha
Alegent Health Bergan Mercy Medical Center, Omaha
Alegent Health Lakeside Hospital, Omaha

Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

Nagre-recruitPhase 2/3

Local Institution - 0286, Omaha

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07221149

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Nagre-recruitPhase 1/2

Nebraska Cancer Specialists, Omaha

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT04198766

Lead-212 PSV359 Therapy for Patients With Solid Tumors

Nagre-recruitPhase 1/2

Nebraska Cancer Specialists, Omaha

Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT06710756

Integrated Cancer Repository for Cancer Research

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Methodist Estabrook Cancer Center, Omaha
Nebraska Methodist Health System, Omaha
University of Nebraska Medical Center, Omaha
at 1 pa

Edad 19 hanggang 110 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT02012699

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

Nagre-recruitPhase 1

Nebraska Cancer Specialists - Omaha - Wright Street /ID# 247399, Omaha

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 23, 2026 · NCT05005403

A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer

Nagre-recruitPhase 3

Nebraska Cancer Specialists, Omaha

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 27, 2026 · NCT06532006

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Omaha

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Pag-aaral para sa Kanser sa Tiyan sa ibang lungsod

Iba pang pag-aaral sa Omaha

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.